Healthcare Lectures and Appearances

ECG pursues a philosophy of professional engagement. We believe that our ability and success as communication consultants in the pharmaceutical industry are enhanced by our active participation in the healthcare community by sharing our expertise in regulatory communication and scientific advocacy.

Recent Lectures and Appearances

American Course Drug Development and Regulatory Sciences

  • Faculty Lecture: "Preparing Focused and Effective Regulatory Communications"
  • Faculty Lecture: "Preparing for an FDA Advisory Committee"

American Association for the Treatment of Opioid Dependence

  • "Countering Opioid Stigma: Communicating Messages to Influence Public Perception"

BIO International Conference

  • Business Development Course: "Communicating the Deal: Achieving Positive Outcomes"

Biotechnology Industry Organization - Licensing Executives Society

  • Business Development Course: "Communicating the Deal"

Ernest Mario School of Pharmacy at Rutgers University

  • Presentation Excellence for PharmD Candidates

European Center for Pharmaceutical Medicine

  • Case Study: "How to Prepare a Scientific Advice Session"
  • Faculty Lecture: "Preparing Regulatory Communication"
  • Faculty Lecture: "Creating Gold Standard Investigator Meetings"

FDA News

PROficiency Conference

  • "PRO in Regulatory Submissions & Launch," with Jean Paty, PhD.
  • Case Study: "The Role of PRO in Successful Product Differentiation"
  • Webinar: "Using PROs to Optimize Comparative Effectiveness Trials"

Regulatory Affairs Professionals Society (RAPS)

  • Annual Exhibitor at RAPS Conference
  • Conference Session: "How to Win Friends and Influence People: Using Professional Development to Refine Communication Skills and Increase Professional Value"
  • Conference Session: "Preparing for a Combination Product Advisory Committee"
  • Conference Session: “Developing an Advisory Committee Strategy”
  • Conference Session: “How to Prepare for a Health Authority Meeting: US and Europe"
  • Conference Session: “Getting the Story Straight: Creating Messages for Submission Documents (NDA, BLA, PMA)"
  • Conference Roundtable: "The Advisory Committee Briefing Document: A New Genre"
  • Conference Roundtable: "The Critical Path to a Successful FDA Advisory Committee Meeting"
  • RAPS Focus Magazine: "Raising the Regulatory Voice"
  • Webinar: "Using Professional Development to Refine Communication Skills and Increase Professional Value"
  • Webinar: "Best Practices for Communicating with Regulatory Agencies in EU / Canada"
  • Webinar:“Giving Voice to Regulatory Leadership”

Society of Toxicologic Pathology

  • Presentation: "Presentation Skills and Scientific Advocacy"
  • Workshop: STP Career Development

University of California, Santa Cruz and San Jose State University

  • Continuing education lectures on regulatory communication

Wall Street Unplugged: Munich, Germany; New York City

  • "From IND to AdComm with Your Scientific Narrative"
  • "Truth, Science, and Health Authorities: The Role of Messages in Drug Development"

Book Chapters

  • "Harmonizing Strategy and Tactics for an FDA Advisory Committee." In Global Pharmaceutical and Biologics Regulatory Strategy, Monica Siegenthaler, PhD & William Sietsema, PhD, Editors.
  • "Preparing for FDA Advisory Committee Meetings." In Expediting Drug and Biologics Development, Third edition, Chapter 34, Steven E. Linberg, Ph.D., Editor.
  • "The FDA Product Advisory Committee: An Overview." In Preparing the New Drug Application: Managing Submissions Amid Changing Global Requirements, William Sietsema

If you'd like one of our ECG consultants to present to your group or association, please contact the ECG Team here.

Library